No Benefit of Eculizumab in Shiga-toxogenic E coli Outbreak
13:21 EDT 9 Jun 2012 | Medscape
Data from an outbreak of Shiga-toxin-producing E coli show that adding eculizumab to therapeutic plasma exchange to treat the accompanying hemolytic uremic syndrome is no better than TPE alone. Medscape Medical News
Original Article: No Benefit of Eculizumab in Shiga-toxogenic E coli Outbreak
More From BioPortfolio on "No Benefit of Eculizumab in Shiga-toxogenic E coli Outbreak"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
